Clinical Trial Update: Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22) [Phase 4]

View source ↗

Summary

TIMI22 is a Phase 4 trial evaluating pravastatin or atorvastatin in patients with acute coronary syndromes; the study status is completed, with no results detai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndromes

Drugs mentioned

• Lipitor (atorvastatin)
• Pravachol (pravastatin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Actue Coronary Syndromes | Phase 4 | Status: COMPLETED